Myelodysplastic syndromes (MDS) are hematological malignancies of unclear etiology where oxidative stress may contribute to the pathogenesis. Methylarginines, naturally occurring inhibitors of NO synthase, can increase superoxide generation from uncoupled NO synthase. We found significant increase in concentrations of asymmetric dimethylarginine (0.84 ± 0.32 μmol/L, p = 0.0022) and malondialdehyde (0.77 ± 0.11 μmol/L, p < 0.001) in sera of MDS patients vs controls (asymmetric dimethylarginine: 0.56 ± 0.16 μmol/L, malondialdehyde: 0.52 ± 0.07 μmol/L). On the contrary, nitrites concentrations were significantly decreased in MDS patients (1.71 ± 0.46 μmol/L, p = 0.0028) vs controls (2.16 ± 0.38 μmol/L). We suppose that the oxidative stress in MDS is enhanced due to methylated arginines influence on NO synthase activity impairment.
Enhanced levels of asymmetric dimethylarginine in a serum of middle age patients with myelodysplastic syndrome
Jana Štikarová,J. Suttnar,K. Pimková,Leona Chrastinová-Mášová,J. Čermák,J. Dyr
Published 2013 in Journal of Hematology & Oncology
ABSTRACT
PUBLICATION RECORD
- Publication year
2013
- Venue
Journal of Hematology & Oncology
- Publication date
2013-08-19
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-11 of 11 references · Page 1 of 1
CITED BY
Showing 1-3 of 3 citing papers · Page 1 of 1